Latest filing published 18 Mar 2021 for Marker Therapeutics, Inc., €2.5M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -82.6%Entry US$24.20 · Close at T+365 US$4.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John Robert Wilson: trading record in brief
John Robert Wilson has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Kalaris Therapeutics, Inc. and Marker Therapeutics, Inc. The record holds 18 filings, for trades running from 9 May 2019 to 16 March 2021.
The open-market side counts 1 purchase for €2.5M alongside 14 sales for €5.3M. Netting one side against the other leaves €2.8M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. So far in 2021, the count stands at 1 purchase and 14 sales.
On 18 March 2021 came the latest disclosure, an open-market purchase for €2.5M in Marker Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John Robert Wilson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,714,285 shares@ US$1.75100.0% of flowCommon StockSEC:0001209191-21-021775:0Canonical exit: 14 Jun 2021 (T+90)
- 52,440 shares@ US$31.3026.2% of flowCommon StockSEC:0000899243-21-011155:0
- 17,480 shares@ US$31.308.7% of flowCommon StockSEC:0000899243-21-011155:1
- 30,506 shares@ US$31.7015.5% of flowCommon StockSEC:0000899243-21-011155:2
- 10,169 shares@ US$31.705.2% of flowCommon StockSEC:0000899243-21-011155:3
- 28,402.75 shares@ US$30.9314.0% of flowCommon StockSEC:0000899243-21-011155:4
- 9,467.25 shares@ US$30.934.7% of flowCommon StockSEC:0000899243-21-011155:5
- 25,256.25 shares@ US$31.5912.7% of flowCommon StockSEC:0000899243-21-011155:6
- 8,418.75 shares@ US$31.594.2% of flowCommon StockSEC:0000899243-21-011155:7
- 900 shares@ US$32.310.5% of flowCommon StockSEC:0000899243-21-011155:8
- 300 shares@ US$32.310.2% of flowCommon StockSEC:0000899243-21-011155:9
- 10,188 shares@ US$30.875.0% of flowCommon StockSEC:0000899243-21-011155:10
- 3,397 shares@ US$30.871.7% of flowCommon StockSEC:0000899243-21-011155:11
- 2,308 shares@ US$31.631.2% of flowCommon StockSEC:0000899243-21-011155:12
- 769 shares@ US$31.630.4% of flowCommon StockSEC:0000899243-21-011155:13
- 3,184,758 sharesCommon StockSEC:0000899243-20-021608:0
- 2,347,999 sharesCommon StockSEC:0000899243-20-021608:1
- 7,260 shares0Common StockSEC:0001144204-19-025607:0
18 of 18 declarations
